stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Return on equity
Doximity, Inc.'s return on equity over the twelve months to 30 September 2026 was 13.8%, down 5.5 percentage points from fiscal 2026 (19.3%). Over the past ten years it has ranged from 0.00% (fiscal 2019) to 63.5% (fiscal 2021); the current reading is higher than 50% of that period. That is above the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 19.3% | (3.22) |
| FY2025 | 22.5% | 6.69 |
| FY2024 | 15.8% | 3.58 |
| FY2023 | 12.2% | (15.96) |
| FY2022 | 28.2% | (35.32) |
| FY2021 | 63.5% | 31.60 |
| FY2020 | 31.9% | 31.91 |
| FY2019 | 0.00% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| HNGE Hinge Health Inc. compare | 41.4% |
| HTFL Heartflow, Inc. compare | 38.5% |
| BTSG BrightSpring Health Services, Inc. compare | 20.5% |
| DOCS Doximity, Inc. | 13.8% |
| HQY HealthEquity, Inc. compare | 11.4% |
| PRVA Privia Health Group, Inc. compare | 4.25% |
| WAY Waystar Holding Corp. compare | 3.72% |
| SDGR Schrodinger, Inc. compare | −19.0% |
| TEM Tempus AI, Inc. compare | −37.6% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement